Fighting cancer with everything we know™
We believe that knowledge is power. And in the fight versus cancer, AccessHope deploys the latest evidence-based recommendations, research, knowledge, and insights to employees and their treating oncologists across the country, regardless of their zip code.
In 2021 and the future, employers are providing their employees with more flexible and personalized benefit options. These options are addressing mental, emotional, and financial health while offering personalized support such as cancer-focused services for those who have received a diagnosis.
Read more
Lung cancer is one of the most common forms of cancer – other than skin cancer, it is second only to prostate cancer for men and breast cancer for women.
Read more
A troubling gap exists between cancer treatment and cancer outcomes. The contributing factors to cancer are complex, such as genetics, differences in access to quality care, and a lack of medical research across diverse study subjects.
Read more
Cancer is a leading cause of mortality in the United States and across the world. It also is one of the major illnesses that cause individuals to worry. Cancer can be diagnosed through screening, when it is asymptomatic, or when symptoms are present.
Read more
Cancer research and treatments are developing at an extraordinary pace, leading to a knowledge gap between large academic institutions and community practices.
Read more
AccessHope achieves HITRUST CSF® Certification. This achievement places AccessHope in an elite group of organizations worldwide that have earned this certification and enables us to serve our customers and people with cancer with the highest standard of security and privacy.
Read more
With almost 2 million new cancer diagnoses every year,1 nearly every person in the United States has been touched by the disease – either personally or through a loved one, friend, or colleague. Fortunately, cancer knowledge is growing rapidly, and researchers are making continuous strides in developing new treatments and advancing diagnostics.
Read more
Breast Cancer Awareness Month is an opportune time to highlight the importance of understanding breast cancer’s impact, undergoing breast screening tests, and conducting breast self-exams.
Read more
Nitya Nathwani, M.D., joined AccessHope as a part of its Expert Oncology Team. Dr. Nathwani’s clinical and research interests center on multiple myeloma. He has been the principal investigator at City of Hope for 2 landmark clinical trials in multiple myeloma, including quadruplet induction therapy that has changed the myeloma treatment landscape, and a trial defining the role of transplant in the US.
Read more
Studies show that academic oncologists are using biomarker testing at a higher percentage than community-based oncologists, despite national guidelines. Learn why, and how cancer experts well-versed in the latest testing and treatments can help close this knowledge gap in cancer care.
Read more